Patent · US Active

Anti-BCMA heavy chain-only antibodies

US11434299B2 · kind B2 · utility

3Cited by

20References

17Claims

0Family size

Assignee

TeneoBio, Inc. · US

Inventors

Shelley Force Aldred · Newark, US
Nathan Trinklein · Redwood City, US
Katherine Harris · Newark, US
Kevin Dang · Newark, US
Wim van Schooten · Sunnyvale, US

Key dates

Filing date	Dec 21, 2017
Grant date	Sep 6, 2022
Priority date	—
Expiry date	Dec 21, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Anti-BCMA heavy chain-only antibodies (HCAb) and disclosed, along with methods of making such antibodies, compositions, including pharmaceutical compositions, comprising such antibodies, and their use to treat B-cell disorders characterized by the expression of BCMA.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.